Pacer Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Sell |
380,155
-116,804
| -24% | -$3.69M | 0.03% | 424 |
|
|
2025
Q1 | $16.5M | Sell |
496,959
-1,782,959
| -78% | -$59.2M | 0.04% | 336 |
|
|
2024
Q4 | $78.5M | Buy |
2,279,918
+351,582
| +18% | +$12.1M | 0.17% | 139 |
|
|
2024
Q3 | $77.1M | Sell |
1,928,336
-581,273
| -23% | -$23.3M | 0.16% | 153 |
|
|
2024
Q2 | $75.7M | Buy |
2,509,609
+14,695
| +0.6% | +$443K | 0.17% | 149 |
|
|
2024
Q1 | $83.8M | Buy |
2,494,914
+1,270,004
| +104% | +$42.6M | 0.19% | 134 |
|
|
2023
Q4 | $39.6M | Buy |
1,224,910
+1,224,681
| +534,795% | +$39.6M | 0.11% | 202 |
|
|
2023
Q3 | $7.5K | Sell |
229
-436,476
| -100% | -$14.3M | ﹤0.01% | 2581 |
|
|
2023
Q2 | $15.4M | Buy |
+436,705
| New | +$15.4M | 0.06% | 281 |
|